Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ · Healthcare
Kiniksa Pharmaceuticals International, plc EPS 2021–2025
Kiniksa Pharmaceuticals International, plc annual/quarterly eps history and growth rate from 2021 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Kiniksa Pharmaceuticals International, plc eps for the quarter ending March 31, 2026 was $0.27, a 145.45% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc annual eps for 2025 was $0.75, a 225.00% decrease from 2024.
- Kiniksa Pharmaceuticals International, plc annual eps for 2024 was $0.60, a 400.00% decrease from 2023.
- Kiniksa Pharmaceuticals International, plc annual eps for 2023 was $0.20, a 92.31% decrease from 2022.
- Kiniksa Pharmaceuticals International, plc annual eps for 2022 was $2.60.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Kiniksa Pharmaceuticals International, plc EPS — FAQ
Kiniksa Pharmaceuticals International, plc (KNSA) eps over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
What is Kiniksa Pharmaceuticals International, plc's eps?
Kiniksa Pharmaceuticals International, plc (KNSA) reported eps of $0.75 for fiscal 2025.
Where can I see KNSA's eps history?
The chart and table above show Kiniksa Pharmaceuticals International, plc's eps by year and by quarter, including the growth rate.